Exact Mass: 375.311

Exact Mass Matches: 375.311

Found 23 metabolites which its exact mass value is equals to given mass value 375.311, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Adrenoyl ethanolamide

(7Z,10Z,13Z,16Z)-N-(2-hydroxyethyl)docosa-7,10,13,16-tetraenamide

C24H41NO2 (375.3137)


Adrenoyl ethanolamide is a N-acylethanolamine. N-acylethanolamines (NAEs) constitute a class of lipid compounds naturally present in both animal and plant membranes as constituents of the membrane-bound phospholipid, N-acylphosphatidylethanolamine (NAPE). NAPE is composed of a third fatty acid moiety linked to the amino head group of the commonly occurring membrane phospholipid, phosphatidylethanolamine. NAEs are released from NAPE by phospholipase D-type hydrolases in response to a variety of stimuli. Transient NAE release and accumulation has been attributed a variety of biological activities, including neurotransmission, membrane protection, and immunomodulation in animals. N-oleoylethanolamine is an inhibitor of the sphingolipid signaling pathway, via specific ceramidase inhibition (ceramidase converts ceramide to sphingosine). N-oleoylethanolamine blocks the effects of TNF- and arachidonic acid on intracellular Ca concentration. (PMID: 12692337, 12056855, 12560208, 11997249) [HMDB] Adrenoyl ethanolamide is a N-acylethanolamine. N-acylethanolamines (NAEs) constitute a class of lipid compounds naturally present in both animal and plant membranes as constituents of the membrane-bound phospholipid, N-acylphosphatidylethanolamine (NAPE). NAPE is composed of a third fatty acid moiety linked to the amino head group of the commonly occurring membrane phospholipid, phosphatidylethanolamine. NAEs are released from NAPE by phospholipase D-type hydrolases in response to a variety of stimuli. Transient NAE release and accumulation has been attributed a variety of biological activities, including neurotransmission, membrane protection, and immunomodulation in animals. N-oleoylethanolamine is an inhibitor of the sphingolipid signaling pathway, via specific ceramidase inhibition (ceramidase converts ceramide to sphingosine). N-oleoylethanolamine blocks the effects of TNF- and arachidonic acid on intracellular Ca concentration. (PMID: 12692337, 12056855, 12560208, 11997249).

   

Docosatetraenylethanolamide

N-(2-Hydroxyethyl)docosa-7,10,13,16-tetraenimidate

C24H41NO2 (375.3137)


   

Pachyaximine B

Pachyaximine B

C24H41NO2 (375.3137)


   

N-(3-Methoxybenzyl)Palmitamide

N-(3-Methoxybenzyl)Palmitamide

C24H41NO2 (375.3137)


   

NA 24:4;O

N-(1,1-dimethy-2-hydroxy-ethyl)-5Z,8Z,11Z,14Z-eicosatetraenoyl amine

C24H41NO2 (375.3137)


N-(3-Methoxybenzyl)palmitamide is a natural product found in Lepidium meyenii with data available. N-(3-Methoxybenzyl)Palmitamide is a promising inhibitor of FAAH for the treatment of pain, inflammation and CNS degenerative disorders[1]. N-(3-Methoxybenzyl)Palmitamide is a promising inhibitor of FAAH for the treatment of pain, inflammation and CNS degenerative disorders[1].

   

N-(1,1-dimethyl-2-hydroxy-ethyl)arachidonoylamide

N-(1,1-dimethy-2-hydroxy-ethyl)-5Z,8Z,11Z,14Z-eicosatetraenoyl amine

C24H41NO2 (375.3137)


   

N-ethyl N-(2-hydroxy-ethyl)arachidonoylamide

N-ethyl-N-(2-hydroxy-ethyl)-5Z,8Z,11Z,14Z-eicosatetraenoyl amine

C24H41NO2 (375.3137)


   

alpha,alpha-dimethyl anandamide

N-(2,2-dimethy-5Z,8Z,11Z,14Z-eicosatetraenoyl)-ethanolamine

C24H41NO2 (375.3137)


   

N-(5Z,8Z,11Z,14Z-docosatetraenoyl)-ethanolamine

N-(5Z,8Z,11Z,14Z-docosatetraenoyl)-ethanolamine

C24H41NO2 (375.3137)


   

5,8,11,14-all-cis-docosatetraenoylethanolamine

N-(5Z,8Z,11Z,14Z-docosatetraenoyl)-ethanolamine

C24H41NO2 (375.3137)


   

NAE 22:4

N-(2,2-dimethy-5Z,8Z,11Z,14Z-eicosatetraenoyl)-ethanolamine

C24H41NO2 (375.3137)


   

hydrogen ionophore iv

hydrogen ionophore iv

C24H41NO2 (375.3137)


   

Octadecanamide,N-(4-hydroxyphenyl)-

Octadecanamide,N-(4-hydroxyphenyl)-

C24H41NO2 (375.3137)


   

Glycerides, tallow mono-, hydrogenated

Glycerides, tallow mono-, hydrogenated

C21H43O5- (375.311)


   

3-Picolinyl stearate

3-Picolinyl stearate

C24H41NO2 (375.3137)


   

(7E,10E,13E,16E)-N-(2-hydroxyethyl)docosa-7,10,13,16-tetraenamide

(7E,10E,13E,16E)-N-(2-hydroxyethyl)docosa-7,10,13,16-tetraenamide

C24H41NO2 (375.3137)


   

(10Z,13Z,16Z,19Z)-N-(2-hydroxyethyl)docosa-10,13,16,19-tetraenamide

(10Z,13Z,16Z,19Z)-N-(2-hydroxyethyl)docosa-10,13,16,19-tetraenamide

C24H41NO2 (375.3137)


   

beta-Picolinyl 4-ethylisopalmitate

beta-Picolinyl 4-ethylisopalmitate

C24H41NO2 (375.3137)


   

N-(1,1-dimethyl-2-hydroxy-ethyl) arachidonoyl amine

N-(1,1-dimethyl-2-hydroxy-ethyl) arachidonoyl amine

C24H41NO2 (375.3137)


   

N-ethyl N-(2-hydroxy-ethyl) arachidonoyl amine

N-ethyl N-(2-hydroxy-ethyl) arachidonoyl amine

C24H41NO2 (375.3137)


   

Docosatetraenoyl-EA

Docosatetraenoyl-EA

C24H41NO2 (375.3137)


   

n-[(3-methoxyphenyl)methyl]hexadecanimidic acid

n-[(3-methoxyphenyl)methyl]hexadecanimidic acid

C24H41NO2 (375.3137)


   

(7z,10z,13z,16z)-n-(2-hydroxyethyl)docosa-7,10,13,16-tetraenimidic acid

(7z,10z,13z,16z)-n-(2-hydroxyethyl)docosa-7,10,13,16-tetraenimidic acid

C24H41NO2 (375.3137)